Genmab (Nasdaq: GMAB) posted a 19% rise in revenue to $715 million for the first quarter of 2025, driven by higher royalties ...

US pharma major Eli Lilly (NYSE: LLY) yesterday announced executive leadership transitions that will further enhance the ...

The US Food and Drug Administration (FDA) has approved Avmapki Fakzynja Co-pack (avutometinib capsules; defactinib tablets) ...

UK pharma major GSK (LSE: GSK) has unveiled full Phase III data showing its experimental drug linerixibat significantly ...

Belgium’s largest drugmaker UCB (Euronext: UCB) today revealed that it has received approval from Japan’s Pharmaceuticals and ...

A preclinical-stage biotech company based in Italy, developing small molecule therapeutics that induce targeted protein ...

US regenerative medicine firm Forever Labs has formally spun out SuperShot as a standalone business, a move the company says ...

The European Commission (EC) has approved a Marketing Authorization (MA) for Tremfya (guselkumab) to treat adults with ...

Positive high-level results have been presented by AstraZeneca (LSE: AZN) from the POTOMAC Phase III trial.

Sweden’s immune-oncology firm Alligator Bioscience today announced the successful completion of the manufacture of the first GMP drug product batch of its lead asset mitazalimab using a new improved ...

UK pharma major AstraZeneca (LSE: AZN) has suffered a setback in its legal fight to block the US government's efforts to lower prescription drug prices, after a federal appeals court dismissed its ...

UK-based specialty pharma business Kelso Pharma has appointed Bee Koen Low as its first chief operating officer (COO).